Tevogen

TVGNNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$50.855 M

$7.81 +5.11%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$26.3M

Loss-making

Shares outstanding

6,511,540

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Tevogen lists more than one class of stock. Company figures above cover all classes combined.

TVGNW

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#126LeonaBioLONA$57.0M
#127ImageneBioIMA$55.1M
#128TevogenTVGN$50.9M
#129Black Hawk AcquisitionBKHA$50.3M
#130Instil BioTIL$48.4M

What if Tevogen were worth as much as…

Open the what-if tool →

Gold $30.2T

$4,643,137

Per share 594,512× higher

Bitcoin $1.74T

$267,472.07

Per share 34,247× higher

Nvidia $5.52T

$847,075.66

Per share 108,460× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Tevogen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.